Dragan Šimić

2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)

Alexander R. Lyon, Teresa López‐Fernández, Liam S. Couch et al. · European Heart Journal · 2022 · 2.8K citations · Full text

Medicine, Hematology, Oncology +17

2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)

Alexander R. Lyon, Teresa López‐Fernández, Liam S. Couch et al. · European Heart Journal - Cardiovascular Imaging · 2022 · 491 citations · Full text

Medicine, Hematology, Oncology +17

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

Kausik K Ray, Helen M Colhoun, Michael Szarek et al. · The Lancet Diabetes & Endocrinology · 2019 · 328 citations · Full text

Medicine, Cardiology, Internal Medicine +15

Empagliflozin after Acute Myocardial Infarction

Javed Butler, W. Schuyler Jones, Jacob A. Udell et al. · New England Journal of Medicine · 2024 · 262 citations · Full text

Medicine, Cardiology, Pharmacotherapy +15

Effect of Empagliflozin on Heart Failure Outcomes After Acute Myocardial Infarction: Insights From the EMPACT-MI Trial

Adrian F. Hernandez, Jacob A. Udell, W. Schuyler Jones et al. · Circulation · 2024 · 89 citations · Full text

Medicine, Cardiology, Pharmacotherapy +14